
    
      This post-market registry is intended to assess the clinical use and safety of the LutonixÂ®
      Drug Coated Balloon Catheter in a heterogeneous patient population in real world clinical
      practice. Up to 500 patients will be enrolled in order to allow identification and assessment
      of rare adverse events (AEs) as well as outcomes in subpopulations defined by subject and
      lesion characteristics. All subjects will be followed for 1 year.

      This registry is performed with marketed devices within the indications for use. There are no
      additional treatments or exams that will take place within this registry.
    
  